Jacob Schwarz

Neuroscience Drug Discovery

Jacob Schwarz has over 20 years of medicinal chemistry experience and has held positions of increasing importance in the Parke-Davis, Pfizer, and Genentech organizations. He is currently Head of Chemistry at ESCAPE Bio, a clinical stage company developing novel, precisely targeted therapies for genetic neurodegenerative diseases. Jake is currently Chair of the American Chemical Society’s Division of Medicinal Chemistry. He received a PhD from Colorado State University under the guidance of A. I. Meyers, followed by an NIH postdoctoral fellowship in the laboratories of Samuel Danishefsky at Memorial Sloan-Kettering Cancer Center.

More from Jacob

Join the Drug Hunter Mailing List

to get free content and resources weekly. Trusted by >8,000 drug hunters worldwide. Unsubscribe anytime.